中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 11
Nov.  2018
Turn off MathJax
Article Contents

Research advances in prognostic factors for patients with esophagogastric variceal bleeding

DOI: 10.3969/j.issn.1001-5256.2018.11.036
Research funding:

 

  • Published Date: 2018-11-20
  • Esophagogastric variceal bleeding is one of the most common complications of liver cirrhosis and is also one of the most critical diseases in the department of gastroenterology, with the features of acute onset and high rebleeding and mortality rates. Strengthening the understanding of related prognostic factors has great clinical significance in reducing early rebleeding rate and mortality rate. There are many factors associated with rebleeding and death in patients with esophagogastric variceal bleeding. Risk factors include advanced age, sex, Child-Turcotte-Pugh class C, low platelet count, high leukocyte count, bleeding history, portal broadening, widening of the portal vein, a positive red-color sign under an endoscope, severe varices, and infection, while the percentage of lymphocytes, serum sodium, and the use of non-selective β-blockers and antibiotics are protective factors. By analyzing these prognostic factors, we can learn more about their mechanisms and risk degree. At present, related research mainly focuses on the exploration of better individual treatment regimens and nursing strategies based on the risk assessment models established using these risk factors to reduce the risk of rebleeding and death.

     

  • loading
  • [1] TENG W, CHEN WT, HO YP, et al. Predictors of mortality within6 weeks after treatment of gastric variceal bleeding in cirrhotic patients[J]. Medicine (Baltimore) , 2014, 93 (29) :e321.
    [2] WANG CF, FAN LJ. Effect of oral carvedilol in the prevention of rebleeding in cirrhotic patients with esophageal varices bleeding after endoscopic treatment[J]. Chin J Integr Tradit West Med Dig, 2017, 25 (10) :755-758. (in Chinese) 王传芳, 樊丽娟.内镜治疗后口服卡维地洛预防肝硬化食管静脉曲张破裂出血患者再出血的效果分析[J].中国中西医结合消化杂志, 2017, 25 (10) :755-758.
    [3] WU H, HU G, FU H, et al. COX regression analysis of prognostic factors in elderly patients with esophagogastric variceal bleeding[J]. Chin J Gerontol, 2018, 38 (3) :600-602. (in Chinese) 吴华, 胡岗, 付华, 等.老年食管胃底静脉曲张破裂出血患者预后影响因素的COX回归分析[J].中国老年学杂志, 2018, 38 (3) :600-602.
    [4] ELSEBAEY MA, ELASHRY H, ELBEDEWY TA, et al. Predictors of in-hospital mortality in a cohort of elderly Egyptian patients with acute upper gastrointestinal bleeding[J]. Medicine (Baltimore) , 2018, 97 (16) :e0403.
    [5] LIN CC, XIAO HB. Related factors for the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Pub Med Forum Magazine, 2016, 20 (27) :3773-3774. (in Chinese) 林婵婵, 肖海滨.肝硬化并食管胃底静脉曲张破裂出血患者预后的相关因素研究[J].基层医学论坛, 2016, 20 (27) :3773-3774.
    [6] WANG Y, LI J, FENG GH. Research advances in the evaluation of liver reserve function based on Child-Turcotte-Pugh class and MELD score[J]. Int J Dig Dis, 2016, 36 (2) :87-91. (in Chinese) 王岩, 李娇, 冯国和.以Child-Turcotte-Pugh分级和终末期肝病模型评分系统为基础评估肝脏储备功能的研究进展[J].国际消化病杂志, 2016, 36 (2) :87-91.
    [7] RADISAVLJEVI M, BJELAKOVI G, JOVI J, et al. Creatinine-modified Child-Turcotte-Pugh score is a good predictor of a short-term survival in patients with bleeding from esophageal varices[J]. Vojnosanit Pregl, 2017, 74 (1) :13-18.
    [8] FORTUNE BE, GARCIA-TSAO G, CIARLEGLIO M, et al.Child-Turcotte-Pugh class is best at stratifying risk in variceal hemorrhage:Analysis of a us multicenter prospective study[J]. J Clin Gastroenterol, 2016.[Epub ahead of print]
    [9] KUMAR AS, SIBIA RS. Predictors of in-hospital mortality among patients presenting with variceal gastrointestinal bleeding[J]. Saudi J Gastroenterol, 2015, 21 (1) :43-46.
    [10] ZHOU JN, WEI Z, SUN ZQ. Risk factors for early rebleeding after esophageal variceal ligation in patients with liver cirrhosis[J]. Chin J Hepatol, 2016, 24 (7) :486-492. (in Chinese) 周嘉宁, 魏志, 孙自勤.肝硬化食管静脉曲张套扎后早期再出血相关危险因素的多中心研究[J].中华肝脏病杂志, 2016, 24 (7) :486-492.
    [11] XU F, HU JL, JIANG ML, et al. Risk factors of esophageal gastric varices bleeding patients with rehaemorrhagia[J]. Proc Clin Med, 2015, 24 (8) :586-589. (in Chinese) 许飞, 胡江玲, 姜曼蕾, 等.食管胃底静脉曲张破裂出血患者再出血的危险因素分析[J].临床医药实践, 2015, 24 (8) :586-589.
    [12] CERQUEIRA RM, ANDRADE L, CORREIA MR, et al. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding[J]. Eur J Gastroenterol Hepatol, 2012, 24 (5) :551-557.
    [13] MIRIDULI WFE, ZHANG ZQ, YAO P, et al. Prognostic factors for patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Chin J Integr Tradit West Med Dig, 2018, 26 (1) :73-77. (in Chinese) 米日古丽·吾甫尔, 张志强, 姚萍, 等.肝硬化食管胃底静脉曲张破裂出血患者预后因素分析[J].中国中西医结合消化杂志, 2018, 26 (1) :73-77.
    [14] HE M, ZOU B, DU YP, et al. An analysis of patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Hebei Med J, 2014, 36 (1) :95-96. (in Chinese) 何敏, 邹兵, 杜意平, 等.肝硬化食管胃底静脉曲张破裂出血分析[J].河北医药, 2014, 36 (1) :95-96.
    [15] ZHANG L, ZHU H. Risk factors and protective factors analysis of short-term prognosis of patients with bleeding esophageal varices[J]. Med J of West China, 2015, 27 (7) :996-998. (in Chinese) 张莉, 朱宏.食管胃底静脉曲张破裂出血患者短期预后的危险与保护因素分析[J].西部医学, 2015, 27 (7) :996-998.
    [16] ZHANG XM, QU HY. Prediction of the early esophageal and gastric varices rebleeding in patients with cirrhosis by serological indexes combined with model for end-stage liver disease[J]. Hainan Med J, 2016, 27 (19) :3126-3128. (in Chinese) 张晓梅, 屈海燕.血清学指标联合终末期肝病模型对肝硬化食管胃静脉曲张早期再出血的预测[J].海南医学, 2016, 27 (19) :3126-3128.
    [17] WANG HB, HU YB, WANG XC. The delta value of end-stage liver disease in prognosis for patients with massive hemorrhage from esophageal varicosis by sclerotherapy[J]. Guide China Med, 2013, 11 (13) :421-422. (in Chinese) 王洪宾, 胡雅兵, 王小春.终末期肝病模型评分差值对食管静脉曲张破裂大出血硬化治疗预后的判断价值[J].中国医药指南, 2013, 11 (13) :421-422.
    [18] CHEN KB, ZHANG JP, LI YH. Value of end-stage liver disease model score/the value of blood sodium ratio in the prognosis of endoscopic sclerotherapy for the cirrhosis esophageal varices rupture and bleeding[J]. Chin J Gastroenterol Hepatol, 2016, 25 (9) :1018-1021. (in Chinese) 陈康部, 张金平, 李岳桓.终末期肝病模型评分/血钠比值对肝硬化食管静脉曲张破裂出血硬化治疗预后判断的价值[J].胃肠病学和肝病学杂志, 2016, 25 (9) :1018-1021.
    [19] CHEN TS. Study of prognosis factors of liver cirrhosis patients with upper gastrointestinal hemorrhage[J]. Hebei Med, 2015, 21 (1) :86-88. (in Chinese) 陈炀森.肝硬化并上消化道出血患者预后的相关因素研究[J].河北医学, 2015, 21 (1) :86-88.
    [20] XU XY, DING HG, JIA JD, et al. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J]. J Clin Hepatol, 2016, 32 (2) :203-219. (in Chinese) 徐小元, 丁惠国, 贾继东, 等.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.
    [21] ZHENG S, TANG YM, YANG JH, et al. Risk factors of esophageal and gastric variceal bleeding in patients with cirrhosis[J]. Chin J Gastroenterol Hepatol, 2014, 23 (2) :178-181. (in Chinese) 郑盛, 唐映梅, 杨晋辉, 等.肝硬化食管胃静脉曲张破裂出血的相关危险因素分析[J].胃肠病学和肝病学杂志, 2014, 23 (2) :178-181.
    [22] HASSANIEN M, EL-TALKAWY MD, EL-GHANNAM M, et al. Predictors of in-hospital mortality in patients with hepatocellular carcinoma and acute variceal bleeding[J]. Electron Physician, 2015, 7 (6) :1336-1343.
    [23] YOSHIDA H, MAMADA Y, TANIAI N, et al. Risk factors for bleeding esophagogastric varices[J]. J Nippon Med Sch, 2013, 80 (4) :252-259.
    [24] WANG MY. Clinical value of degree of varices and Child-Pugh score in predicing rebleedig in patients with gastroesophageal variceal bleeding[J]. World Chin J Dig, 2017, 25 (26) :2387-2393. (in Chinese) 王明友.静脉曲张程度、Child评分预测食管胃静脉曲张破裂出血患者再出血的临床价值[J].世界华人消化杂志, 2017, 25 (26) :2387-2393.
    [25] PENG PL, ZHOU XY. Risk factors for esophagogastric variceal bleeding in patients with liver cirrhosis and a prognostic analysis[J]. J Clin Med Pract, 2016, 20 (9) :171-173. (in Chinese) 彭湃澜, 周翔禹.肝硬化食管胃底静脉曲张破裂出血的危险因素及预后分析[J].实用临床医药杂志, 2016, 20 (9) :171-173.
    [26] WANG F, SHEN JL, HUA J, et al. Studies of the application of spectral ct evaluating the grading of esophageal varices of liver cirrhosis[J]. J Clin Radiol, 2016, 35 (2) :208-212. (in Chinese) 王芳, 沈加林, 华静, 等.能谱CT评估肝硬化食管静脉曲张程度的价值研究[J].临床放射学杂志, 2016, 35 (2) :208-212.
    [27] LIU GH, YAN ZH. Investigation of the relationship between the liver cirrhosis portal hemodynamic change under color ultrasound and esophageal varicealrupture hemorrhage[J]. J Clin Exp Med, 2016, 15 (23) :2338-2341. (in Chinese) 刘桂红, 严志涵.彩超下肝硬化门脉血流动力学改变与食管静脉曲张破裂出血的关系研究[J].临床和实验医学杂志, 2016, 15 (23) :2338-2341.
    [28] NI M, ZHANG HY. Clinical efficacy of endoscopic variceal ligation combined with sclerotherapy in the treatment of patients with hepatitis B liver cirrhosis and esophageal variceal bleeding[J]. J Pract Hepatol, 2018, 21 (2) :241-244. (in Chinese) 倪猛, 张海洋.内镜下套扎联合硬化剂注射治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者疗效及其再出血危险因素分析[J].实用肝脏病杂志, 2018, 21 (2) :241-244.
    [29] VIVAS S, RODRIGUEZ M, PALACIO MA, et al. Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding[J]. Dig Dis Sci, 2001, 46 (12) :2752-2757.
    [30] KOMORI K, KUBOKAWA M, IHARA E, et al. Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding[J]. World J Gastroenterol, 2017, 23 (3) :496-504.
    [31] GOULIS J, PATCH D, BURROUGHS AK. Bacterial infection in the pathogenesis of variceal bleeding[J]. Lancet, 1999, 353 (9147) :139-142.
    [32] ZUO-HUA G, CHEN-CHI T, KUO-CHIH T, et al. The effect of bacterial infections in cirrhotic patients with esophageal variceal bleeding[J]. Ann Hepatol, 2014, 13 (3) :364-369.
    [33] de SOUZA AR, LA MURA V, BERZIGOTTI A, et al. Prognosis of acute variceal bleeding:Is being on beta-blockers an aggravating factor? A short-term survival analysis[J]. Hepatology, 2015, 62 (6) :1840-1846.
    [34] MARTINEZ J, TELLEZ L. Acute variceal bleeding in patients on primary prophylaxis with nonselective beta-blockers:A poor prognosis factor?[J]. Hepatology, 2017, 65 (5) :1774.
    [35] LIU XY, SU HB. Application of non-selectiveβ-blockers in patients with liver cirrhosis[J]. J Clin Hepatol, 2017, 33 (11) :2214-2217. (in Chinese) 刘晓燕, 苏海滨.非选择性β-受体阻滞剂在肝硬化患者中的应用进展[J].临床肝胆病杂志, 2017, 33 (11) :2214-2217.
    [36] LEE YY, TEE HP, MAHADEVA S. Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding[J]. World J Gastroenterol, 2014, 20 (7) :1790-1796.
    [37] YU ZG, LIN YH, HUANG WF, et al. Clinical efficacy and safety of different endoscopy methods in patients with liver cirrhosis complicated with esophagogastric varicosity bleeding[J]. J Clin Exp Med, 2018, 17 (8) :813-816. (in Chinese) 余中贵, 林燕华, 黄文峰, 等.不同内镜方案对肝硬化合并食管胃底静脉曲张破裂出血患者临床疗效及安全性分析[J].临床和实验医学杂志, 2018, 17 (8) :813-816.
    [38] BUCSICS T, SCHODER M, DIERMAYR M, et al. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal rebleeding—A two decades experience[J]. PLo S One, 2018, 13 (1) :e0189414.
    [39] LU CY, CHEN YZ. Drugs combined with endoscopic therapy versus transjugular intrahepatic portosystemic shunt in management of esophageal and gastric variceal bleeding.[J]. China J Endosc, 2018, 24 (1) :34-38. (in Chinese) 卢承毅, 陈永忠.药物联合内镜治疗与经颈静脉肝内门体分流术对肝硬化食管胃静脉曲张出血的疗效分析[J].中国内镜杂志, 2018, 24 (1) :34-38.
    [40] ZHANG H, ZHANG H, LI H, et al. TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis:A meta-analysis update[J]. J Huazhong Univ Sci Technolog Med Sci, 2017, 37 (4) :475-485.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1425) PDF downloads(416) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return